DK3401392T3 - Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound. - Google Patents

Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound. Download PDF

Info

Publication number
DK3401392T3
DK3401392T3 DK17736049.2T DK17736049T DK3401392T3 DK 3401392 T3 DK3401392 T3 DK 3401392T3 DK 17736049 T DK17736049 T DK 17736049T DK 3401392 T3 DK3401392 T3 DK 3401392T3
Authority
DK
Denmark
Prior art keywords
cells
hepatic
molecular
low
weight compound
Prior art date
Application number
DK17736049.2T
Other languages
English (en)
Inventor
Takahiro Ochiya
Takeshi Katsuda
Original Assignee
Evia Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evia Life Sciences Inc filed Critical Evia Life Sciences Inc
Application granted granted Critical
Publication of DK3401392T3 publication Critical patent/DK3401392T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • C12N5/0672Stem cells; Progenitor cells; Precursor cells; Oval cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/407Liver; Hepatocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067Liver cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases [EC 2.]
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/04Screening or testing on artificial tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/54Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
DK17736049.2T 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound. DK3401392T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016003088 2016-01-08
PCT/JP2017/000342 WO2017119512A1 (ja) 2016-01-08 2017-01-06 低分子化合物による成熟肝細胞からの肝幹/前駆細胞の作製方法

Publications (1)

Publication Number Publication Date
DK3401392T3 true DK3401392T3 (da) 2022-03-07

Family

ID=59273713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17736049.2T DK3401392T3 (da) 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound.

Country Status (13)

Country Link
US (1) US10961507B2 (da)
EP (1) EP3401392B1 (da)
JP (1) JP7063624B2 (da)
KR (1) KR20180114032A (da)
CN (1) CN108779439B (da)
AU (1) AU2017205801A1 (da)
CA (1) CA3010808A1 (da)
DK (1) DK3401392T3 (da)
ES (1) ES2908707T3 (da)
PL (1) PL3401392T3 (da)
RU (1) RU2018128598A (da)
SG (2) SG11201805846TA (da)
WO (1) WO2017119512A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109890956A (zh) * 2016-10-28 2019-06-14 国立研究开发法人国立癌研究中心 人肝前体细胞的制备方法
WO2018097127A1 (ja) * 2016-11-22 2018-05-31 国立大学法人京都大学 肝芽細胞から胆管上皮前駆細胞への段階的誘導方法
EP3868870A4 (en) * 2018-10-15 2022-10-19 Evia Life Sciences Inc. METHOD OF GENERATING STEM/PROGENIOR CELLS USING SMALL MOLECULAR COMPOUNDS FROM CELLS DERIVED FROM AN ENDODERMAL TISSUE OR ORGAN
JP7284985B2 (ja) * 2019-03-29 2023-06-01 国立大学法人 長崎大学 肝前駆細胞を含む細胞集団を製造する方法
CN110013544B (zh) * 2019-04-23 2021-04-30 中国人民解放军第二军医大学 小分子组合在制备治疗慢性肝损伤的药物中的应用
EP4379045A1 (en) 2021-07-29 2024-06-05 Tokyo Medical University Method for producing highly proliferative cell, and highly proliferative cell and use thereof
CA3235384A1 (en) 2021-10-18 2023-04-27 Takahiro Ochiya Compositions and methods of use thereof for treating liver fibrosis
EP4419120A2 (en) 2021-10-22 2024-08-28 Evia Life Sciences Inc. Methods for making extracellular vesicles, and compositions and methods of use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08163996A (ja) * 1994-12-13 1996-06-25 Sumitomo Bakelite Co Ltd 動物細胞毒性試験方法
JPH08308562A (ja) * 1995-05-16 1996-11-26 Sumitomo Bakelite Co Ltd 動物細胞培養器及びそれを用いる薬物代謝活性の測定方法
JP2000189189A (ja) 1998-12-24 2000-07-11 Jms Co Ltd 細胞による評価試験方法とそのための装置
JP2004198150A (ja) 2002-12-17 2004-07-15 Banyu Pharmaceut Co Ltd 薬物の肝代謝速度予測方法及び薬物間相互作用の予測方法
JP2006254896A (ja) 2005-01-07 2006-09-28 Effector Cell Institute Inc ヒト肝細胞様細胞およびその利用
DK2281875T3 (da) 2005-12-21 2018-06-06 Univ Catholique Louvain Isolerede leverstamceller
RU2008130098A (ru) 2005-12-22 2010-01-27 Веста Терапьютикс, Инк. (Us) Способ лечения нарушения функции печени с использованием печеночных клеток-предшественников
WO2009117439A2 (en) * 2008-03-17 2009-09-24 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
US20100209404A1 (en) * 2009-02-10 2010-08-19 University Of Dayton Enhanced method for producing stem-like cells from somatic cells
ES2638464T3 (es) * 2009-10-16 2017-10-20 The Scripps Research Institute Inducción de células pluripotentes
KR101646308B1 (ko) 2010-02-03 2016-08-05 데츠야 이시카와 유도간 간세포 및 그 제조 방법, 그리고 그 세포의 응용
KR102703637B1 (ko) * 2010-12-22 2024-09-05 페이트 세러퓨틱스, 인코포레이티드 단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
JP6124347B2 (ja) 2011-08-02 2017-05-10 石川 哲也 TGF−βシグナリング阻害剤および/またはY−27632による肝前駆細胞の誘導方法および製造方法、並びに当該肝前駆細胞から肝細胞の製造方法
WO2014025046A1 (ja) 2012-08-09 2014-02-13 独立行政法人国立がん研究センター 肝前駆細胞から肝細胞への分化促進剤及びその用途
JP6113999B2 (ja) 2012-10-18 2017-04-12 株式会社クラレ 化合物のスクリーニング方法
CN105143445B (zh) * 2012-11-29 2020-07-07 宝生物欧洲公司 衍生自人多能干细胞的肝细胞样细胞的成熟
JPWO2014058080A1 (ja) * 2012-11-30 2016-09-05 国立研究開発法人理化学研究所 体細胞のリプログラミングを亢進させる方法、及び細胞作製キット
CN105658786B (zh) 2013-08-28 2020-07-03 普罗米迪拉生物科学公司 用于生产成人肝脏祖细胞的方法
CN105154386B (zh) * 2014-05-30 2018-04-24 中国人民解放军第二军医大学东方肝胆外科医院 人肝细胞长期维持和增殖传代培养的专用培养基和培养方法

Also Published As

Publication number Publication date
ES2908707T3 (es) 2022-05-03
SG10202006104YA (en) 2020-07-29
EP3401392A1 (en) 2018-11-14
EP3401392B1 (en) 2022-02-23
PL3401392T3 (pl) 2022-06-27
US10961507B2 (en) 2021-03-30
CN108779439A (zh) 2018-11-09
KR20180114032A (ko) 2018-10-17
JPWO2017119512A1 (ja) 2018-11-15
JP7063624B2 (ja) 2022-05-09
RU2018128598A (ru) 2020-02-11
SG11201805846TA (en) 2018-08-30
AU2017205801A1 (en) 2018-08-16
WO2017119512A1 (ja) 2017-07-13
CA3010808A1 (en) 2017-07-13
US20190010464A1 (en) 2019-01-10
CN108779439B (zh) 2023-05-30
EP3401392A4 (en) 2019-09-18

Similar Documents

Publication Publication Date Title
DK3401392T3 (da) Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound.
SG10201600557XA (en) Wafer producing method
SG10201600552YA (en) Wafer producing method
DK3140393T3 (da) Fremstillingsmetode for voksne leverstamceller
SG10201510271QA (en) Wafer producing method
EP3524575C0 (en) METHOD FOR PRODUCING A LITHIUM COMPOUND
BR112016025255A2 (pt) métodos para produzir carbonatos alcalino-terrosos
EP3318543A4 (en) PROCESS FOR PREPARING AN ORGANIC COMPOUND
SI3386947T1 (sl) Postopek za pripravo N-retinoilaminoalkansulfonske kisline
FI20165264A (fi) Menetelmä hemiselluloosauutteiden tuottamiseksi
EP3156395A4 (en) Method for producing heteroaromatic sulfonamide compound
SG11201705230WA (en) Method for producing aldehyde compound, and acetal compound
IL250223A0 (en) A method for the preparation of the pyrimidin-1-ol compound, and its intermediates
DK3386703T3 (da) Fremgangsmåde til fremstilling af et prækursormateriale
EP3357898A4 (en) PROCESS FOR PRODUCING ORGANIC COMPOUND
BR112016030358A2 (pt) Método para a preparação de 4-alcóxi-1, 1, 1, trifluorobut-3-en-2-onas a partir de 1,1,1- trifluoroacetona
DK3285572T3 (da) Fremgangsmåde til fremstilling af insulinproducerende celler
FR3018389B1 (fr) Procede de fabrication de lamelles bistables de courbures differentes
TH1601003416A (th) วิธีสำหรับการผลิตโครงสร้างคล้ายโซนขอบรอยต่อซิลิเอรี
EP3246307A4 (en) Method for producing diamine precursor compound
ITUB20153925A1 (it) Metodo per produrre porzioni discrete autoadesive.
TH1601003366A (th) วิธีการผลิตส่วนประกอบที่มีภาคตัดขวางเป็นรูปทรงคล้ายหมวก
TH1301001552B (th) วิธีการผลิตไวนิล-ซิส-โพลีบิวตะไดอีน และไวนิล-ซิส-โพลีบิวตะไดอีนที่ได้จากวิธีการดังกล่าว
TH1501005716A (th) วิธีการผลิตไอโซยาเนต (Method for Producing lsocyanate)
TH1601003770A (th) องค์ประกอบสำหรับการขึ้นรูปแม่พิมพ์,วิธีการสำหรับการผลิตแม่พิมพ์ที่เคียวตัวเองได้, และชุดสำเร็จสำหรับการขึ้นรูปแม่พิมพ์ที่เคียวตัวเองได้